RG
Redmile Group Portfolio holdings
AUM
$940M
This Quarter Return
-16.09%
1 Year Return
+75.78%
3 Year Return
+543.67%
5 Year Return
+585.96%
10 Year Return
+6,653.82%
AUM
$1.65B
AUM Growth
+$1.65B
(-39%)
Cap. Flow
-$554M
Cap. Flow
% of AUM
-33.52%
Top 10 Holdings %
Top 10 Hldgs %
45.81%
Holding
77
New
–
Increased
9
Reduced
35
Closed
14
Top Buys
| 1 |
Replimune Group
REPL
|
$16.5M |
| 2 |
Cogent Biosciences
COGT
|
$7.06M |
| 3 |
Intuitive Surgical
ISRG
|
$4.58M |
| 4 |
Annexon
ANNX
|
$4.53M |
| 5 |
Establishment Labs
ESTA
|
$4.48M |
Top Sells
| 1 |
Krystal Biotech
KRYS
|
$89.5M |
| 2 |
DCPH
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
|
$83.3M |
| 3 |
Atara Biotherapeutics
ATRA
|
$74.9M |
| 4 |
Abbott
ABT
|
$29.8M |
| 5 |
Align Technology
ALGN
|
$28.6M |
Sector Composition
| 1 | Healthcare | 99.13% |
| 2 | Industrials | 0.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
LAVA Therapeutics
LVTX
$41.6M
| $3.73M | 0.23% |
2,074,372
| – | – |
|
52
Invivyd
IVVD
$211M
| $3.37M | 0.2% |
3,065,714
+1,624,989
| +113% | +$1.79M |
|
53
Cabaletta Bio
CABA
$141M
| $3.31M | 0.2% |
442,826
| – | – |
|
|
GRTS
54
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
| $3.16M | 0.19% |
5,107,732
-647,343
| -11% | -$400K |
|
|
ALLK
55
DELISTED
Allakos
ALLK
| $3.08M | 0.19% |
3,077,828
-373,248
| -11% | -$373K |
|
56
Xeris Biopharma Holdings
XERS
$1.25B
| $2.35M | 0.14% |
1,046,587
| – | – |
|
57
RAPT Therapeutics
RAPT
$192M
| $1.64M | 0.1% |
536,682
-125,716
| -19% | -$383K |
|
|
KLRS
58
Kalaris Therapeutics, Inc. Common Stock
KLRS
$77.8M
| $1.38M | 0.08% |
1,907,969
| – | – |
|
|
ACHL
59
DELISTED
Achilles Therapeutics plc American Depositary Shares
ACHL
| $1.31M | 0.08% |
1,608,089
| – | – |
|
60
Standard BioTools
LAB
$477M
| $729K | 0.04% |
411,631
| – | – |
|
|
ADAP
61
Adaptimmune Therapeutics
ADAP
$14.6M
| $698K | 0.04% |
715,607
| – | – |
|
|
HOOK
62
DELISTED
HOOKIPA Pharma
HOOK
| $630K | 0.04% |
1,063,769
| – | – |
|
63
Alpha Teknova
TKNO
$226M
| $212K | 0.01% |
154,509
-16,944
| -10% | -$23.2K |
|
|
64
Abbott
ABT
$228B
| – | – |
-262,371
| Closed | -$29.8M |
|
|
65
Align Technology
ALGN
$9.57B
| – | – |
-87,255
| Closed | -$28.6M |
|
66
Apellis Pharmaceuticals
APLS
$3.52B
| – | – |
-155,000
| Closed | -$9.11M |
|
67
Cigna
CI
$80.1B
| – | – |
-65,435
| Closed | -$23.8M |
|
68
Quest Diagnostics
DGX
$20B
| – | – |
-83,849
| Closed | -$11.2M |
|
69
Elanco Animal Health
ELAN
$8.55B
| – | – |
-676,039
| Closed | -$11M |
|
70
Elevance Health
ELV
$72.4B
| – | – |
-31,223
| Closed | -$16.2M |
|
71
Evolent Health
EVH
$1.09B
| – | – |
-679,172
| Closed | -$22.3M |
|
72
HCA Healthcare
HCA
$94.9B
| – | – |
-52,487
| Closed | -$17.5M |
|
73
Icon
ICLR
$14B
| – | – |
-36,949
| Closed | -$12.4M |
|
74
McKesson
MCK
$85.6B
| – | – |
-20,707
| Closed | -$11.1M |
|
75
Penumbra
PEN
$10.5B
| – | – |
-44,613
| Closed | -$9.96M |
|